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Abstract 
Mechanisms responsible for the differences in humoral immune response to GAT (a random linear amino 
acid polymer) were investigated in a line of chickens consisting of four sublines homozygous for Ea-B (B1 
or B19) and high or low antibody response to GAT (Ir-GATH or Ir-GATL). Previous research provided 
evidence of chromosomal recombination between the serologically determined regions of the MHC 
(encoded by B-F and B-G genes) and the gene or genes that control immune response to GAT, but immune 
response to GAT did not seem to be mediated through differences in B-L gene products. In the present 
study, proliferation of GAT-primed T lymphocytes indicated that reactivity in vitro was not associated with 
antibody levels produced in the animal. Cell surface markers were identified by flow cytometry. 
Lymphocytes from Ea-B19 chickens that were Ir-GATL had a higher percentage of suppressor T (CD8)-
positive cells than did lymphocytes from Ir-GATH chickens. The Ea-B1 chickens that were Ir-GATL had a 
higher percentage of CD4-positive lymphocytes than did chickens that were Ir-GATH. This may indicate 
that low response to GAT in the Ea-B19 chickens, but not in Ea-B1 chickens, is mediated by CD8-positive 
cells. The ability of antigen-presenting cells (APC) to process and present GAT to antigen-primed T 
lymphocytes was tested in vitro. Measurements of lymphocyte proliferation indicated that, within the Ea-
B1 blood type, APC from Ir-GATL chickens produced higher (P < .05) stimulation of both GAT low- and 
GAT high-responder lymphocytes. It is possible that, between the two B blood types, there are different 
mechanisms responsible for the differential response to GAT. 
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T Lymphocyte Reactivity to Glutamic Acid-Alanine-Tyrosine In 
Vitro Does Not Reflect Antibody Response In Vivo1 
E. M. STEADHAM and S. J. LAMONT2 
Department of Animal Science and the Immunobiology Program, 
Iowa State University, Ames, Iowa 50011 
ABSTRACT Mechanisms responsible for the differences in humoral 
immune response to GAT (a random linear amino acid polymer) were 
investigated in a line of chickens consisting of four sublines homozygous for 
Ea-B (B1 or B19) and high or low antibody response to GAT (Ir-GAT" or Ir-
GATL). Previous research provided evidence of chromosomal recombination 
between the serologically determined regions of the MHC (encoded by B-F 
and B-G genes) and the gene or genes that control immune response to GAT, 
but immune response to GAT did not seem to be mediated through 
differences in B-L gene products. In the present study, proliferation of GAT-
primed T lymphocytes indicated that reactivity in vitro was not associated 
with antibody levels produced in the animal. Cell surface markers were 
identified by flow cytometry. Lymphocytes from Ea-B19 chickens that were 
Ir-GATL had a higher percentage of suppressor T (CD8)-positive cells than 
did lymphocytes from Ir-GAT1^ chickens. The Ea-B1 chickens that were Ir-
GAT^ had a higher percentage of CD4-positive lymphocytes than did 
chickens that were Ir-GATH. This may indicate that low response to GAT in 
the Ea-B19 chickens, but not in Ea-B1 chickens, is mediated by CD8-positive 
cells. The ability of antigen-presenting cells (APC) to process and present 
GAT to antigen-primed T lymphocytes was tested in vitro. Measurements of 
lymphocyte proliferation indicated that, within the Ea-B1 blood type, APC 
from Ir-GAT^ chickens produced higher (P < .05) stimulation of both GAT 
low- and GAT high-responder lymphocytes. It is possible that, between the 
two B blood types, there are different mechanisms responsible for the 
differential response to GAT. 
(Key words: immune response, glutamic acid-alanine-tyrosine, genetic differ-
ences, chickens, major histocompatibility complex) 
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INTRODUCTION 
Although Ir-GAT is linked to the B 
blood group in chickens, Pevzner et al. 
(1978) reported the recombination be-
tween the gene or genes responsible for 
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immune response to GAT (Ir-GATH or Ir-
GAT1-, detected as high or low antibody 
production) and genes coding for the 
serologically detectable MHC antigens 
(Ea-B). The ability, or lack thereof, in mice 
to produce antibody after challenge with 
particular amino acid polymers has been 
mapped to the immune response region (I) 
of the MHC (McDevitt et al, 1972). Based 
on structural and functional homology, 
the gene products of the B-L region of the 
chicken MHC are the equivalent of the 
mouse immune response region genes 
(Hala et al, 1981). This suggested that the 
recombination between Ir-GAT and the 
67 
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serologically detectable MHC gene 
products may have reflected recombina-
tion within the chicken MHC. 
Attempts to detect chromosomal 
recombination within the MHC of the line 
with recombination between Ir-GAT and 
Ea-B, as expressed by a difference in cell 
surface protein (B-L) have not supported 
this hypothesis. Extensive reciprocal im-
munizations between Ir-GAT" and Ir-
GATL chickens with B-L antigen-positive 
cells have not resulted in antibody that 
could discriminate between GAT pheno-
types (Steadham, 1991). Restriction frag-
ment length polymorphisms generated by 
probing SI line DNA with a Class II (B-L 
a) gene probe (Pitcovski et al., 1989) or a 
Class I (B-F) gene probe (Chen and 
Lamont, 1992) have been associated with 
Ea-B differences, but not with Ir-GAT 
differences. Results indicate that, although 
the humoral response to GAT may be 
linked to the chicken MHC (Benedict et al, 
1975), the response may not be controlled 
by traditional Class I or Class II genes 
within the MHC. 
The importance of Ir-GAT as a marker 
for disease resistance has been well inves-
tigated in the chicken. For example, inci-
dence of Marek's disease in Marek's 
disease virus (MDV)-challenged chickens 
is low in the SI line chickens that have the 
BlB1 blood type compared with the B19B19 
blood type. Within the B^B1 blood type, 
chickens that are high responders to GAT 
are yet more resistant to MDV challenge 
(Pevzner et al, 1981; Steadham el al, 1987). 
This effect is also seen when more suscep-
tible chickens [such as the SI line (B19!?*9) 
chickens] are challenged with MDV; that 
is, the Ir-GATH chickens within the blood 
type are more resistant to incidence of the 
disease than Ir-GATL chickens. Pevzner et 
al. (1989a, b) conducted a divergent selec-
tion experiment within two types of 
commercial chickens (broilers and layers). 
After development of sublines that were 
low or high antibody responders to GAT 
challenge, the chickens were tested for 
their resistance to poultry pathogens 
3Miles Laboratories, Elkhart, IN 46515. 
4Gibco Laboratories, Grand Island, NY 14072. 
ssigma Chemical Co., St. Louis, MO 63178-9916. 
(MDV, Rous sarcoma virus, and 
Staphylococcus aureus). The lines selected 
for high antibody response to GAT were 
more resistant to incidence of disease or 
the effects of the disease than were the 
low-responder lines. Equally important, 
selection for high GAT response did not 
result in any significant change in perfor-
mance characteristics. 
Although the results of selecting for 
high GAT response could result in 
healthier chickens, the underlying im-
munological mechanisms are poorly de-
fined. The purpose of the present study 
was to examine some of the cellular 
reactions that contribute to immune re-
sponse. 
MATERIALS AND METHODS 
Genetic Stocks 
The SI line of chickens originated from a 
cross of two commercial inbred lines (Nord-
skog et al, 1973). Since 1978 the line has 
been maintained in sublines selected for 
homozygous Ea-B serotype {filBx or Bl9B19) 
and for humoral immune response (high or 
low) to the amino acid polymer GAT 
(Pevzner et al, 1978). The inbreeding coeffi-
cients of the SI sublines were approxi-
mately .52 (Nordskog and Cheng, 1988). 
Chickens used were of both sexes and 
between 12 and 16 wk of age unless 
otherwise noted. 
Lymphocyte Culture 
In vitro proliferation of T lymphocytes 
induced by GAT was assayed by a proce-
dure modified from Vainio et al. (1988). 
Blood was collected 14 days after chickens 
were primed by intramuscular GAT immu-
nization (250 /xg GAT in .5 mL of .01M PBS 
pH 7.2 emulsified in .5 mL of complete 
Freund's adjuvant). All immunizations 
were done with the same lot number of 
GAT3 and complete Freund's adjuvant.4 
Peripheral blood lymphocytes (PBL) were 
separated from whole blood by centrifuga-
tion over Histopaque 10775 density gra-
dient. The lymphocyte fraction was asepti-
cally collected and washed three times in 
culture medium (RPMI1640 supplemented 
with 2 mM L-glutamine, 100 U/mL penicil-
IN VITRO RESPONSE TO GLUTAMIC ACID-ALANINE-TYROSINE 69 
lin, 100 jtg/mL streptomycin, 5% heat-
inactivated normal chicken serum, and 5 x 
10-5 M 2-mercaptoethanol). After the last 
wash, the cells were resuspended in 
medium and the concentrations were ad-
justed to 1 x 107 cells per milliliter. 
Cell suspensions (100 fiL) were added to 
sterile, flat-bottomed, 96-well tissue culture 
plates.6 Each well received an additional 
100 /iL of medium with or without GAT 
such that the final GAT concentration was 0, 
1, or 10 fig per well. After a 3-day incubation 
at 41 C in a humidified, 5% CO2 incubator, 
proliferation was measured by 3-(4,5-
dimethyl-thiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay. 
MTT Proliferation Assay 
The T cell proliferation in vitro was 
determined by a colorimetric assay based 
on the cleavage of MTT by living cells 
(Mosmann, 1983). After a 3-day incubation, 
20 fiL of MTT stock solution (10 mg/mL 
MTT in .01 M PBS, pH 7.2) was added to 
each well of the cultured cells. The plate 
was returned to the incubator for additional 
incubation. At the end of 3 h, 150 /*L of 
medium was removed, without disturbing 
the cells, from each well and 150 ^L of acid-
isopropanol (3.3 mL of 12 N HC1/L 
isopropanol). The plate was then vortexed 
to ensure lysis of the cells and to dissolve 
the cleaved MTT. Absorbance at 570 nm 
was determined for each well on an ELISA 
plate reader.7 Data presented represent the 
mean absorbance at 570 nm of quadrupli-
cate wells cultured under the same condi-
tions. 
Fluorescent Labeling of 
Cultured Cells 
Cell-surface phenotypes of cultured cells 
receiving secondary exposure to GAT in 
vitro were determined by flow cytometric 
analysis of fluorescent antibody-labeled 
cells. Cells collected for analysis were 
cultured as described. Nonadherent cul-
6Flow Laboratories Inc., McLean, VA 22102. 
TModel ELISA Reader, Fisher Scientific Co., Itasca, 
IL 60143. 
"Coulter Co., Hialeah, FL 33012. 
tured cells were placed in siliconized glass 
tubes and washed once in cold (4 C) wash 
buffer (1.1 x Dulbecco's PBS plus 2% of 
heat-inactivated fetal calf serum and .1% 
NaNa) before labeling. The harvested cul-
tured cells were resuspended in 100 jtL of 
primary antibody dilution (anti-CD4 or 
anti-CD8) or wash buffer only (for controls). 
The cells were incubated for 30 min at 4 C. 
After incubation, the cells were washed 
three times with cold (4 C) wash buffer, and 
the second antibody was added. 
The primary antibodies were mono-
clonal antibodies (as hybridoma culture 
supernatants) obtained from two sources. 
The anti-CD8 was a gift from Hyun Lillehoj 
(USDA, Agricultural Research Service, 
Beltsville, MD 20705) and was used at a 
dilution (in wash buffer) of 1:10. The anti-
CD8 antibody identifies a population 
chicken T lymphocytes of the cytotoxic or 
suppressor functional type (Lillehoj et dl., 
1988). The anti-CD4 monoclonal antibody 
(also used at 1:10 dilution) was a gift from 
Chen-lo Chen (University of Alabama, 
Birmingham, AL 35294). The anti-CD4 
antibody identifies a molecule that is the 
avian homolog of the surface marker on T 
cells of the helper phenotype (Chan et ah, 
1988). The secondary antibody was 
fluoroisothiocyanate-conjugated rabbit 
anti-mouse IgG F(ab')2 fragments diluted 1: 
100 with wash buffer. 
Washed cells were resuspended in 100 
f/L of the second antibody dilution and 
incubated for an additional 30 min at 4 C. 
Controls received no primary or secondary 
antibody or received secondary antibody 
only. After the second incubation, the cells 
were washed three times with cold (4 C) 
wash buffer. After the last wash, the cells 
were fixed by first suspending the cells in 
200 /*L of 1.1 x Dulbecco's PBS with .1% 
NaN3 and then adding 200 /*L of parafor-
maldehyde solutions (2% paraformalde-
hyde in 1.1 x Dulbecco's PBS with .1% 
NaN3). Samples were refrigerated in the 
dark until analyzed by using flow cytome-
try. 
Labeled cells were analyzed on an EPICS 
Profile I flow cytometer.8 Lymphocyte 
populations were selected for fluorescence 
analysis on the basis of forward light scatter 
versus side light scatter (size versus 
granularity) histograms. The analyzed lym-
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phocyte populations represented an aver-
age of 84% of the cultured cells analyzed 
through the flow cytometer. Results were 
recorded as percentage fluorescence-
positive cells (within gated fluorescence 
window) of 4 x 103 cells tested. 
In Vitro Antigen-Presenting 
Cell Assay 
Plastic-adherent cells from Histopaque 
1077-isolated PBL were used as antigen-
presenting cells (APC) for in vitro stimula-
tion of in two-primed T cells. Adherent 
monolayer cells are primarily monocyte-
macrophage cells (Chu and Dietert, 1989) 
and were prepared by a method used by 
Vainio et al. (1988). Peripheral blood lym-
phocytes were first isolated from whole 
blood of GAT-primed chickens by gradient 
centrifugation over Histopaque 1077. The 
mononuclear cell layer was collected, 
washed three times in RPMI 1640 (sup-
plemented with 2 mM L-glutamine, 100 U/ 
mL penicillin, 100 /ig/mL streptomycin, 5% 
heat-inactivated normal chicken serum, 
and 5 x 10~5 M 2-mercaptoethanol), and the 
cell concentration was adjusted to 5 x 106 
cells per milliliter. The cell dilutions (200 /xL 
per well) were placed into 96-well plates 
and incubated for 3 h in a humidified, 41 C, 
5% CO2 incubator to allow cell adherence to 
occur. Then the nonadherent cells were 
washed away (3x) with prewarmed (41 C) 
medium. Medium with GAT (0 to 10 /*g per 
well) was added to the remaining adherent 
cells. The plates were returned to the 
incubator for a 5-h antigen pulse. 
Following the antigen pulse, the APC 
cultures were prepared by thrice washing 
the adherent cells with supplemented 
medium (without GAT) to remove the 
noninternalized GAT. The responder lym-
phocytes from GAT-primed chickens were 
prepared as described previously and 1 x 
106 cells in 200 /*L of medium without 
antigen were added to each well. 
Responder cells and APC were combined 
within Ea-B type (to avoid mixed lympho-
cyte proliferative reaction) and were 
matched or mismatched by Ir-GAT type. 
The cultures were incubated for 3 days 
before proliferation was determined by the 
MTT proliferation assay. Results were con-
verted to a stimulation index by dividing 
the mean absorbance of wells with GAT by 
the mean absorbance of the same cultures 
without GAT. The resulting value was 
multiplied by 100 and subtracted from 100. 
Thus, index scores above zero indicated 
proliferation above control values, and 
negative values indicated suppression be-
low control values. The chickens used for 
these assays were hens over 52 wk of age. 
Statistical Analysis 
Where significant differences are 
reported, analyses of variance were per-
formed on assay results by using the traits 
under consideration (e.g., Ea-B or Ir-GAT), 
sex, and GAT concentrations as sources of 
variation. Differences between means were 
tested by Duncan's multiple range test or t 
test (SAS Institute, 1985). 
RESULTS 
Table 1 presents the results of in vitro 
proliferation (mean absorbance at 570 nm) 
for the four Ea-B and Ir-GAT combina-
tions. There were no statistically signifi-
TABLE 1. Mean proliferation response (absorbance at 570 nm) of T lymphocytes, from birds 

















.78 ± .06" 
.64 ± .03b 
.51 ± .04b 
.54 ± .05b 
GAT concentration (j*g per well) 
1 10 
.81 ± .06* .84 ± .06" 
.66 ± .03b .68 ± .03b 
.51 ± .04= .57 ± .04bc 
.54 ± .04bc .54 ± .04c 
a_cMeans ± SE within a column with no common superscripts differ significantly in absorbance (P < .05). 
1Ir-GAT = phenotypic immune response to GAT. 
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TABLE 2. Analyses of variance of factors 
influencing in vitro proliferative response 
in vivo-primed T-cells within GAT 
concentration of medium 
GAT concentration 
0*g per well) 
0 10 
Source of variation df MS df MS df MS 
EaB type 
Ir-GAT type 














*P < .05. 
***P < .001. 
cant differences between GAT concentra-
tions within Ea-B or Ir-GAT type. Within a 
concentration of GAT, there were differ-
ences by Ea-B and Ir-GAT type. These 
differences reflect the different ability of 
cells of a particular haplotype to prolifer-
ate under these particular culture condi-
tions. At both concentrations of GAT, and 
in cultures without GAT, cells from B19B19 
chickens that were high responders to 
GAT (Ir-GATH) had the highest mean 
absorbance at 570 nm. 
The Ea-B and Ir-GAT type of the 
chickens were used as sources of variation 
in an analysis of variance (Table 2). Sex of 
the donor was not a significant source of 
variation so sex was omitted from the 
model. At each concentration of GAT, the 
Ea-B type of the donor was a significant 
source of variation (P < .001) with prolifer-
ation of B19B19 cells being higher than 
B1B1. At the highest GAT concentration 
(10 /xg per well), Ir-GAT was a significant 
source of variation (P < .05). 
Table 3 presents the mean percentage of 
CD4-positive lymphocytes for the three 
GAT concentrations used to culture cells 
from the four sublines. The percentage of 
positive cells did not differ within subline 
when the concentration of GAT in the 
culture medium changed. There were 
significant differences (P < .05) between 
sublines associated with Ea-B type. Cul-
tures from B19B19 chickens generally had a 
higher percentage of CD4-positive cells. If 
results were analyzed within Ea-B type, 
there was no significant difference in 
percentage CD4-positive cells between Ir-
GAT11 or Ir-GATL samples from B19B19 
chickens. Within the B^B1 blood type, the 
cultures from Ir-GATL chickens had a 
higher percentage of CD4-positive cells (P 
< .05) if the cells were cultured at 10 fig 
GAT per well. Sex of the donor chicken 
was never a significant source of variation 
in percentage CD4-positive cells in any 
instance. 
Table 3 also presents the mean percent-
age of CD8-positive cells for the four SI 
sublines. The percentage CD8-positive did 
not differ within subline by GAT concen-
tration; there were differences between 
sublines at each concentration of GAT 
used in the culture medium. The cultures 
from B19B19 Ir-GATL chickens had the 
highest percentage of CD8-positive cells. 
At each concentration of GAT in the 
medium, Ea-B type was a significant 
TABLE 3. Percentage of CD4- and CD8-positive (+) cells determined by flow cytometry after culture 
at one of three concentrations of GAT of in vivo primed lymphocytes from chickens of SI sublines 
Ea-B 
B19B19 









49.2 ± 5.3a 17.7 ± 1.3b 
47.6 ± 4.1a 22.1 ± 1.5a 
31.5 ± 2.8b 15.8 ± 1.0b 
40.5 ± 5.0ab 15.4 ± 1.0b 
GAT concentration (/tg per 
1 
CD4+ CD8+ 
52.6 ± 3.9a 17.1 ± 1.2b 
48.9 ± 3.9a 22.1 ± 1.5a 
36.0 ± 2.5b 14.8 ± 1.2b 




50.4 ± 4.0a 16.5 ± 1.5b 
49.2 ± 3.6a 22.8 ± 1.9a 
32.4 ± 2.7b 15.7 ± 1.0b 
44.0 ± 4.6a 15.6 ± 4.6b 
a.bMeans ± SE within a column with no common superscripts differ significantly in percentage positive 
lymphocytes (P < .05). 
!Ir-GAT = phenotypic immune response to GAT. 
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source of variation (P < .05). At the 
1- and 10-/*g GAT per well concentrations, 
Ir-GAT type of the donor chicken was a 
significant source of variation (P < .05). 
There was no difference in percentage 
CD8-positive cells on the basis of sex of 
the chicken. Analyzed within blood type 
(gi9gi9 o r B^B1), there was a significant 
difference (P < .05) in percentage CD8-
positive cells associated with Ir-GAT type 
of the donor chicken within the B19B19 
blood type. Samples from Bl9B19 chickens 
that were Ir-GATL had a higher percent-
age of CD8-positive cells when cultured at 
either concentration of, or without, GAT. 
Within the B^B1 blood type, there were no 
differences associated with Ir-GAT type. 
The APC from GAT-primed chickens 
were used to establish cultures that mixed 
or matched Ir-GAT types of APC and in 
vivo primed responder lymphocytes. Table 
4 presents the mean stimulation index 
scores (percentage of control) for the eight 
culture combinations assayed. The 
ANOVA were calculated within Ea-B type. 
Within B ^ 1 blood type, the Ir-GAT type 
of the APC was a significant source of 
variation (P < .05). The APC from Ir-GATL 
chickens presented antigen better to 
responder lymphocytes of either Ir-GAT 
type than did the Ir-GATH APC. The Ir-
GAT type of the responder lymphocytes 
was not a significant source of variation. 
Within the B"9B19 blood type, the means 
were not significantly different. 
DISCUSSION 
Measurements of in vitro reactivity of 
antigen (GAT)-primed lymphocytes were 
undertaken to determine whether there 
were differences in proliferation in re-
sponse to GAT that could account for the 
differences in humoral anti-GAT response 
in the whole animal. The Ir-GAT type of 
the responder cells was a significant 
source of variation in proliferation (as 
measured by MTT assay) only at the 
10-/*g per well concentration of GAT. 
Within a subline, there were no differ-
ences in proliferation between levels of 
GAT. The T cell reactivity to GAT is not 
likely to be the cause of the difference in 
antibody response in these chickens, in 
contrast with similar experiments con-
ducted with mouse cells (Kimoto and 
Fathman, 1980; Gougeon and Theze, 1983). 
Gougeon and Theze (1983) used cells from 
GAT responder and nonresponder mouse 
lines as source of antigen-primed lympho-
cytes. Subsequent secondary stimulation 
in vitro resulted in proliferation of 
responder mouse cells above levels seen 
for cells in wells without GAT. Cells from 
nonresponder mice did not proliferate in 
vitro. 
The proliferation assay results might 
have been different if exogenous interleu-
kin 2 (IL-2) had been added to the 
medium. The IL-2 would have allowed for 
a longer incubation time for proliferation 
differences to occur, and there is a syner-
gistic effect when antigen and IL-2 are 
used to induce proliferation. At present, 
however, there is no consistent public 
source of chicken IL-2 other than using 
conditioned medium (the medium into 
which mitogen-stimulated T cells have 
TABLE 4. Mean (± SE) in vitro proliferation index score for different combinations 
of in vivo-piimed aivtigen-presenting cells (APC) and responder lymphocytes1 










-2.1 ± 1.2 
-3.8 ± 2.9 
3.6 ± 1.6 
6.6 ± 2.3 
-1.5 ± 1.1 
-2.4 ± 1.1 
.1 ± 2.4 
1.7 ± 1.9 
B^B1 Ir-GATH 





















high phenotypic immune response to GAT. Ir-GATL = low phenotypic immune response to 
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secreted IL-2), and mammalian IL-2 is not 
biologically active on chicken lymphocytes 
(Schauenstein et al., 1982). Conditioned 
medium not only contains IL-2 but also 
any mitogen that cannot be removed or 
inactivated and all other soluble factors 
secreted by the mitogen-stimulated cells. 
The total proliferative response to 
secondary GAT exposure in vitro may not 
be as significant an indicator of antibody-
producing potential as the functional type 
of cells that proliferate in response to the 
antigen. For example, cell numbers would 
not have to increase substantially to 
change the response if all the cells prolifer-
ating were antigen-specific and of either 
the suppressor or helper functional type 
(bearing CD8 or CD4 surface molecules, 
respectively). Small changes in popula-
tions of CD4- and CD8-positive cells can 
result in major differences in immune 
reactivity. Hala et al. (1991) has reported 
differences in basal levels of CD4 and CD8 
lymphocytes in congenic lines of chickens 
that differ in their resistance to Rous 
sarcoma virus-induced tumors and in their 
humoral immune response to various 
antigens. 
Gougeon and Theze (1983) demon-
strated in vitro T cell proliferation in 
response to GAT in nonresponder mice by 
first deleting the suppressor T cells from 
the cell cultures. Pierce et al. (1988) 
showed that T cell populations that were 
induced in GAT nonresponder mice were 
specific for the antigen and had the 
phenotypic marker (CD8) of suppressor 
cells. Nonresponse to GAT in mice is 
seemingly mediated through antigen-
specific suppressor T cells. In both of the 
previous examples, T cells from non-
responder mice could respond to GAT 
under the appropriate conditions; thus, 
nonresponse was not due to inability of 
the cells to recognize antigen. 
The percentage of CD4- and CD8-
positive cells in the present study did not 
change as a result of different concentra-
tions of GAT in the culture medium, but 
there were differences resulting from be-
ing cultured. Freshly collected lympho-
cytes from Sl-line chickens have been 
assayed to determine the percentage of 
CD4 and CD8 populations (Munns, 1990). 
Cells from BlB* Ir-GATH chickens had the 
highest percentage of CD4 expression, and 
B^B1 Ir-GATL chickens were the lowest for 
percentage CD8 expression, with no sig-
nificant differences between the other SI 
sublines for either marker. The cultured 
cells from BxBl Ir-GATH chickens had the 
lowest percentage of CD4-positive cells, 
and cells from B19B19 Ir-GATL chickens 
had the highest number of CD8-positive 
cells. 
It is possible that there are different 
mechanisms responsible for the differen-
tial humoral immune response to GAT 
within the two Ea-B types of the SI line. 
The sublines within the SI line originally 
arose from the same genetic group, but 
some selection had taken place already 
within some of the sublines. Some of the 
ancestors of the current B1!?1 sublines 
were drawn from populations that had 
been previously selected for antibody 
response to Salmonella pullorum (Pevzner et 
al, 1977, 1978). Within the B19B19 blood 
type, low response to GAT could be 
mediated by induction of suppressor T 
cells (CD8-positive). Within the B ^ 1 blood 
type, low response to GAT could be due 
to a completely unrelated mechanism. 
There are examples in which differences 
in levels of antibody produced can be 
attributed to differences in the ability of 
APC to process and present antigen. Some 
lines of "Biozzi" mice produce low levels 
of antibody because of the inability of 
their APC to present antigen to responsive 
T cells (Adorini and Doria, 1981). 
When lymphocytes from GAT-primed 
chickens were cultured with GAT-pulsed 
APC from Ir-GATH or Ir-GATL chickens, 
the APC from the Ir-GATL chickens were 
better able to stimulate the responder 
cells, regardless of their GAT response 
phenotype. If APC defects were responsi-
ble for the differences seen in humoral 
immune response to GAT, the expectation 
would be that the APC from high-
responder chickens would be more capa-
ble of presenting antigen than APC from 
low-responder chickens. The APC assayed 
in vitro did not support the hypothesis 
that there was a defect in antigen presen-
tation in the SI low-responders. Defective 
antigen presentation is not always the 
cause of low antibody production. Of the 
five different lines of "Biozzi" mice 
74 STEADHAM AND LAMONT 
(selected for divergent antibody produc-
tion to different antigens) tested, deficient 
antigen presentation was a likely cause of 
low antibody production in only two of 
the lines (Biozzi et al, 1984; Mouton et al, 
1984). 
Humoral immune response to GAT in 
chickens may be determined at levels of 
cell interaction other than those mediated 
through Class II MHC molecules. There 
are other cellular interactions that could 
result in differences in humoral antibody 
response. For example, there could be 
differences in antigen processing or 
presentation by antigen-presenting cells 
(Adorini and Doria, 1981) or differences in 
effector cell populations (Hala et al, 1991). 
The response and phenotypic markers of 
antigen-primed lymphocytes secondarily 
exposed to GAT in vitro was assayed to 
clarify the nature of antibody response to 
GAT in chickens. 
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